Melanopsin System Dysfunction in Smith-Magenis Syndrome Patients

Area of Science:

• Ophthalmology
• Neuroscience
• Genetics

Background:

• Smith-Magenis syndrome (SMS) is a genetic disorder characterized by significant sleep disturbances.
• The underlying mechanism linking the genomic disorder to disrupted sleep-wake rhythms and abnormal melatonin profiles in SMS remains unclear.
• The intrinsically photosensitive retinal ganglion cell (ipRGC) system, mediated by melanopsin, plays a crucial role in regulating melatonin synthesis via light inhibition.

Purpose of the Study:

• To investigate the integrity of the ipRGC/melanopsin system in Smith-Magenis syndrome patients.
• To evaluate the impact of SMS on pupillary light responses (PLR) as a measure of retinal light perception.
• To correlate findings with known melatonin production abnormalities in SMS.

Main Methods:

• Pupillary light responses were recorded in SMS patients (n=5) and healthy controls (n=4).
• Visual stimuli included brief red light flashes (640 nm) and blue light flashes (470 nm), targeting melanopsin activation.
• Melatonin levels were previously measured over 24 hours for SMS patients.

Main Results:

• SMS patients displayed normal pupillary responses to red light flashes.
• Responses to blue light flashes revealed an altered sustained pupillary constriction in SMS patients, with faster recovery to baseline.
• Impaired suppression of melatonin production during daytime was confirmed in SMS patients.

Conclusions:

• SMS patients exhibit dysfunction in the sustained pupillary light response to blue light, indicating a potential issue with melanopsin-driven photoreception.
• This retinal dysfunction likely contributes to the abnormal melatonin profiles and elevated daytime melatonin levels observed in SMS.
• The findings suggest a deficit in melanopsin-based photoreception or possibly rod function, impacting the synchronization of the daily melatonin rhythm.